Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

1.9%

8 terminated/withdrawn out of 424 trials

Success Rate

92.3%

+5.7% vs industry average

Late-Stage Pipeline

13%

53 trials in Phase 3/4

Results Transparency

4%

4 of 96 completed trials have results

Key Signals

113 recruiting4 with results5 withdrawn

Enrollment Performance

Analytics

N/A
136(52.7%)
Phase 2
48(18.6%)
Phase 4
29(11.2%)
Phase 3
24(9.3%)
Phase 1
11(4.3%)
Early Phase 1
10(3.9%)
258Total
N/A(136)
Phase 2(48)
Phase 4(29)
Phase 3(24)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (424)

Showing 20 of 424 trials
NCT07844551Phase 2Not Yet Recruiting

ImmunoADC Therapy for Induction Conversion in Patients With Stage IVB OSCC/OPSCC

Role: lead

NCT06288659Not ApplicableActive Not Recruiting

aSAH Treatment Based on Intraventricular ICP Monitoring: A Prospective, Multicenter, Randomized and Controlled Trial

Role: lead

NCT05391789Phase 3Completed

Clinical Efficacy of Ulinastatin for Treatment of Sepsis With Systemic Inflammatory Response Syndrome

Role: lead

NCT04433455Recruiting

Influencing Factors of Cerebrovascular Disease and Cognition in Hemodialysis Patients

Role: lead

NCT07834450Phase 2Not Yet Recruiting

Efficacy and Safety of Cyclophosphamide in Amyotrophic Lateral Sclerosis

Role: lead

NCT06623266Not ApplicableRecruiting

Neck Observation or Elective Neck Dissection in cT1N0M0 OSCC

Role: lead

NCT06829524Recruiting

HANDLE-a Real World Study on Satralizumab in NMOSD

Role: lead

NCT04698304Completed

The Efficacy of Endovascular Treatment in FPOD With TASC C and D Lesions

Role: collaborator

NCT06617962Recruiting

Evaluation of Two Cell-based Assays for Diagnosing MOG-IgG Associated Disorders

Role: lead

NCT07821957Not ApplicableRecruiting

A Multicenter Prospective Study of New Flow Diverter Stent on the Treatment of Intracranial Aneurysms in China

Role: collaborator

NCT07809178Not Yet Recruiting

China Treatment Trial for Tumor in Sellar Region With Unruptured Intracranial Aneurysm

Role: collaborator

NCT07799584Not ApplicableRecruiting

Temporal Interference Stimulation Combined With Tai Chi for Mild Cognitive Impairment

Role: collaborator

NCT07790354Phase 3Not Yet Recruiting

APEX-STROKE EAGLE Domain (EAGLE)

Role: collaborator

NCT07752719Phase 3Not Yet Recruiting

APEX-STROKE CALM-ICH Domain

Role: collaborator

NCT07784569Phase 3Not Yet Recruiting

APEX-STROKE Adaptive Platform Trial for Stroke

Role: collaborator

NCT06990412Not ApplicableCompleted

A Clinical Trial to Evaluate the Safety and Efficacy of an Implantable Wireless Brain-Computer Interface(BCI)System NEO in Patients With Tetraplegia

Role: collaborator

NCT07778368Phase 2Not Yet Recruiting

A Multicenter, Prospective, Phase II Study of TROP-2 ADC in Combination With Toripalimab for Resectable Locally Advanced Oral Squamous Cell Carcinoma

Role: collaborator

NCT07775768Not Yet Recruiting

Emergence Delirium、fBFI-ENO Score (Extraversion + Neuroticism - Openness) Based on the Fast Big Five Personality Scale-10、An Adult Patient With ASAI-III Who is Scheduled for Elective Non-cardiac Surgery and is to Undergo General Anesthesia With Tracheal Intubation

Role: collaborator

NCT06112067Not ApplicableRecruiting

Efficacy and Safety of Combo-stim Deep Brain Stimulation for Treatment-refractory Mental Disorders

Role: collaborator

NCT07185373Phase 2Recruiting

Orelabrutinib Combined With Teniposide, Rituximab and Methotrexate for Newly Diagnosed PCNSL

Role: lead